Team Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65K Buy
+1,000
New +$69.1K 0.03% 107
2026
Q2
– Sell
-1,000
Closed -$54.1K – 265
2026
Q1
$54.1K Hold
1,000
– – 0.02% 106
2025
Q4
$56K Buy
+1,000
New +$51.8K 0.03% 97

Other funds holding XPH

Team Financial Group's XPH Position: Q3 2026 in Review

Team Financial Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 1,000 shares worth $65K. The stake represents 0.03% of the portfolio and ranks #107 among its holdings. This is a return to the name: Team Financial Group previously reported a position in XPH as recently as Q1 2026.

Team Financial Group first reported a position in XPH in Q4 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Team Financial Group held 1,000 shares of State Street SPDR S&P Pharmaceuticals ETF worth $65K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Team Financial Group position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.03% of Team Financial Group's portfolio in Q3 2026, its #107 holding.
  • Team Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Team Financial Group's 13F filing for Q3 2026, filed 30 Oct 2026.